Back

Pharma

3rd Sustainable Medicine & Environment Summit

  • 22nd – 23rd May 2025
  • Germany flag Germany Berlin

Join us at the 3rd Sustainable Medicine & Environment Summit on May 22-23, 2025, in Berlin, Germany, where industry leaders will explore sustainable healthcare practices and environmental stewardship. The summit delves into innovative green technologies in pharmaceutical manufacturing and strategies to reduce the environmental impact of medical waste.  

This summit offers a platform to learn practical applications from professionals leading these advancements. Don’t miss the chance to network with experts driving sustainability in healthcare and shape the future of sustainable medicine. 

Read more

About the 3rd Sustainable Medicine & Environment Summit

The 3rd Sustainable Medicine & Environment Summit is an annual event that gathers industry leaders, experts, and professionals in the healthcare and environmental sectors. Taking place on May 22-23, 2025 in Berlin, Germany, the summit will serve as a platform to discuss the latest discoveries, best practices, and emerging technologies related to sustainable healthcare practices and environmental stewardship in the medical and pharmaceutical industries. In the ever-evolving landscape of healthcare delivery and environmental conservation, sustainability has become increasingly critical. To remain competitive and responsible, businesses must not only adhere to environmental regulations but also understand the complexities of sustainable practices and their implications for successful implementation. This summit aims to delve into the crucial aspect that sustainability frameworks are gradually enhancing and, in some cases, revolutionizing traditional healthcare processes. However, it emphasizes that mere adherence to environmental guidelines does not guarantee a successful transformation. Attendees of this summit will have the opportunity to seek answers to some of the most pressing challenges faced in the field. Key topics of discussion will include implementing successful sustainability strategies throughout the product lifecycle, exploring eco-friendly drug development processes, and optimizing waste management through innovative technologies. These issues, among others, will be addressed by industry professionals who are at the forefront of innovation and strategy in sustainable healthcare and environmental practices. We are honored to host this prestigious summit and extend an invitation for your participation. We look forward to your involvement in May, as we collectively shape the future of sustainable medicine and environmental responsibility in the healthcare industry.  

 

Who Should Attend  

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists and Engineers specialising in: 

  • Sustainability in Healthcare
  • Environmental Management
  • Pharmaceutical Manufacturing
  • Medical Device Development
  • Hospital Administration
  • Supply Chain Management
  • Research & Development
  • Regulatory Affairs
  • Quality Assurance
  • Waste Management
  • Energy Management
  • Corporate Social Responsibility
  • Green Chemistry
  • Circular Economy
  • Environmental Health and Safety

Register by November 30

The Early Bird Offer expires in 45 days!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

KEY PRACTICAL LEARNING POINTS

  • Sustainable pharmaceutical manufacturing processes
  • Green chemistry in drug development
  • Circular economy principles in medical device design
  • Reducing environmental impact of medical waste
  • Sustainable hospital management practices
  • Eco-friendly packaging solutions for pharmaceuticals
  • Carbon footprint reduction strategies in healthcare
  • Water conservation in pharmaceutical production
  • Renewable energy adoption in healthcare facilities
  • Sustainable supply chain management in healthcare
  • Environmental impact assessments for new medical technologies
  • Biodegradable materials in medical products

Register by November 30

The Early Bird Offer expires in 45 days!

Jürgen Wieland, CH

Development Environmental Sustainability Lead

Novartis

Novartis has set ambitious environmental sustainability targets to achieve carbon neutral own operations by 2025, plastic neutrality and water sustainability by 2030, and net-zero by 2040.  Novartis was recently recognized by CDP as the only big pharma company globally with a Double-A leadership rating in the Climate Change and Water Security categories.

Jürgen’s role as Environmental Sustainability lead for Novartis’ global development organization covers the set-up and execution of low carbon clinical trials. On top, Jürgen is in charge of the company-wide target of “all new products meet sustainable design principles by 2030”, which spans from research up to commercial.  Jürgen represents Novartis within two workstreams of the Sustainable Markets Initiative (SMI) Health System Task Force and within the Sustainable Healthcare Coalition’s industry low carbon clinical trial workstream.

Jürgen has been very engaged and passionate about the topic of environmental sustainability for more than three decades. Prior to joining Novartis in 2011, he was the CFO of the NGO Solar Energy Foundation, supporting the roll-out of solar energy in rural East Africa. From 2015-20, he was the finance head of Novartis’ global clinical supply unit, during which he was awarded with the Novartis “Better World Award for Environmental Sustainability” for significant progress in the decarbonisation of clinical trials.

Richard Hall Hall, ES

Business Development/Chair – ASTM E55.11 Process Design

Rattiinox

Richard Hall is a mechanical engineer with several decades experience in the hydraulics industry - selling hydraulic cylinders to global manufacturers of construction and agricultural equipment (Caterpillar, John Deere, Kubota, Bobcat, etc.). He provides active, hands-on managerial support of continuous process improvement methods (SMED, 5S, Kaizen, VSM, etc.) and introduction of new production processes.

Richard has works in business development for Rattiinox (aseptic valve manufacturer) and is a non-voting member of four ASME BPE task groups: CIP, Valve certification, Appendix K (valve testing), and vessel certification. He's also been a member of ISPE since 2011, as well as PDA, A3P, and ASTM E55 since 2021.

He's the technical lead of ASTM E55.11: Clean by Design task group (80 members), and he's writing new standards for the specification, design, manufacture, and FAT test (CIP-cleanability test - not just coverage test) of pharmaceutical manufacturing systems that are rapid to clean robustly with CIP, using 50-80% less water and energy. Richard is also the chair of ASTM E55 subcommittee E55.11 Process Design.

Dr. Michael Hell, DE

Head of Environmental Sustainability, Global Healthcare Operations

Merck Healthcare KGaA

Dr. Michael Hell is a chemist (MSc) and cell biologist (PhD) by education with substantial experience in manufacturing and operations of biopharmaceuticals. Before being appointed to head of sustainability at Merck’s Healthcare operations, he was leading environment, health, and safety for Merck KGaA’s global biotech manufacturing and led a packaging, logistics, and visual inspection operation unit.

Michael brings a diverse background in manufacturing, spanning environment, health, and safety, strategy development, continuous improvement/LEAN, operations, and business consulting. He is an active member of ISPE and chaired conference tracks or contributed as speaker. Michael co-authored scientific papers or book chapters.

Christopher Nial, IR

Senior Partner, EMEA Public Health Co-Lead

FINN Partners

Christopher Nial is a senior partner at FINN Partners and is based in Ireland. His career, spanning over three decades, is marked by a deep commitment to enhancing global public health. Christopher’s journey in this field is distinguished by his unique focus on the critical intersection of climate change and public health. This specialised approach reflects his belief in the profound impact of environmental factors on global health outcomes.

His collaborations with both profit and non-profit organisations further highlight Christopher's impact. He has played a pivotal role in advancing the missions of major pharmaceutical giants like MSD, Sanofi, GSK, and Roche, and influential non-profits such as the Bill & Melinda Gates Foundation, Gavi, and PATH. His contributions to these organisations underscore his dedication to shaping a healthier, more sustainable future, making him a respected figure in global public health and climate advocacy.

Jürgen Wieland, CH

Development Environmental Sustainability Lead

Novartis

Richard Hall Hall, ES

Business Development/Chair – ASTM E55.11 Process Design

Rattiinox

Dr. Michael Hell, DE

Head of Environmental Sustainability, Global Healthcare Operations

Merck Healthcare KGaA

Christopher Nial, IR

Senior Partner, EMEA Public Health Co-Lead

FINN Partners

BROCHURE 

Request the 3rd Sustainable Medicine & Environment Summit brochure and find out the latest topics and ideas that will be shared.   

Request

Please fill in your e-mail address below and we will process your request in a moment.

What our
participants
are saying

“I want to extend my gratitude and appreciation for providing such a quality platform for this very important part of our industry!”

1
2
3
4
5

Robert B. Wood IV

Scientist II at FUJIFILM Diosynth Biotechnologies

"We had very interesting discussions with the different participants about our industry and the latest trends. Thanks to Vonlanthen for organizing another great 4.0 oriented event."

1
2
3
4
5

Paolo Bento

Regional Sales Manager at ILC

"Big thank you to all the speakers at the #VLSustainMed Summit. Fantastic insights from a diverse group of industry experts and great presentations from all involved."

1
2
3
4
5

Jessica Pearson

Occupational Hygiene Consultant at Armstrong Environmental